Veterans Affairs Medical Center - Salt Lake City
Claim this profile,
Global Leader in Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
104 reported clinical trials
9 medical researchers
Summary
Veterans Affairs Medical Center - Salt Lake City is a medical facility located in undefined, undefined. This center is recognized for care of Lung Cancer, Leukemia, Lymphoma, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Veterans Affairs Medical Center - Salt Lake City is involved with conducting 104 clinical trials across 110 conditions. There are 9 research doctors associated with this hospital, such as Sumati V. Gupta, Shiven Patel, Sarah V. Colonna, and Jana Wold, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage I
Stage II
2Leukemia
BCR-ABL positive
Stage I
Stage II
Top PIs
Sumati V. GuptaHuntsman Cancer Institute/University of Utah5 years of reported clinical research
Studies Bladder Cancer
Studies Cancer
7 reported clinical trials
29 drugs studied
Shiven PatelGeorge E Wahlen Department of Veterans Affairs Medical Center5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
14 drugs studied
Sarah V. ColonnaHuntsman Cancer Institute/University of Utah3 years of reported clinical research
Studies Cancer
Studies Tumors
3 reported clinical trials
6 drugs studied
Jana Wold, MDGeorge E. Wahlen Department of Veterans Affairs Medical Center6 years of reported clinical research
Studies Ischemic Stroke
Studies Stroke
3 reported clinical trials
7 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Salt Lake City
Diffuse Large B-Cell Lymphoma
Prostate Cancer
Lymphoma
Renal Cell Carcinoma
B-Cell Lymphoma
Pulmonary Arterial Hypertension
Chronic Obstructive Pulmonary Disease
Cancer
Follicular Lymphoma
Heart Failure
Oral Azacitidine + R-miniCHOP
for Diffuse Large B-Cell Lymphoma
This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone \[R-miniCHOP\]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. R-miniCHOP includes a monoclonal antibody (a type of protein), called rituximab, which attaches to the lymphoma cells and may help the immune system kill these cells. R-miniCHOP also includes prednisone which is an anti-inflammatory medication and a combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Combining oral azacitidine with R-miniCHOP may shrink the cancer or extend the time without disease symptoms coming back or extend patient's survival when compared to R-miniCHOP alone.
Recruiting1 award Phase 2 & 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Salt Lake City?
Veterans Affairs Medical Center - Salt Lake City is a medical facility located in undefined, undefined. This center is recognized for care of Lung Cancer, Leukemia, Lymphoma, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Veterans Affairs Medical Center - Salt Lake City is involved with conducting 104 clinical trials across 110 conditions. There are 9 research doctors associated with this hospital, such as Sumati V. Gupta, Shiven Patel, Sarah V. Colonna, and Jana Wold, MD.